Generation Bio

Generation Bio company information, Employees & Contact Information

Updated May 2026

Quick answer

Generation Bio is a Biotechnology Research company and founded in 2016. It has approximately 121 employees on record. Contact data was last refreshed in May 2026. Find Generation Bio's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Generation Bio email format Generation Bio management contacts

Related company profiles:

Generation Bio is a biotechnology company changing what is possible for people living with T cell-driven autoimmune diseases. The company is developing a new modality of therapeutics leveraging its T cell selective cell-targeted lipid nanoparticle (ctLNP) to deliver siRNA in vivo, enabling modulation of T cell activity that causes inflammation and auto-reactive tissue destruction.

Company Details

Employees
121
Founded
-
Address
301 Binney Street,
Email
in****@****bio.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
generationbio.com
Keywords
Biotechnology, LNPs, siRNA, Autoimmune Disease, T cells.
HQ
Cambridge, Massachusetts
Competitors
Alnylam Pharmaceuticals, Tessera Therapeutics, Verve Therapeutics, Orna Therapeutics, Vertex Pharmaceuticals, Flagship Pioneering, Beam Therapeutics, Editas Medicine, Generate:Biomedicines, Intellia Therapeutics, Inc..
Looking for a particular Generation Bio employee's phone or email?

Generation Bio Questions

News

Generation Bio CEO Geoff McDonough, MD to Step Down - citybiz

Generation Bio CEO Geoff McDonough, MD to Step Down citybiz

Geoff McDonough Steps Down as CEO of Generation Bio, Yalonda Howze Appointed Interim CEO - Quiver Quantitative

Geoff McDonough Steps Down as CEO of Generation Bio, Yalonda Howze Appointed Interim CEO Quiver Quantitative

Generation Bio (NASDAQ: GBIO) names Howze interim CEO; McDonough to chair board - Stock Titan

Generation Bio (NASDAQ: GBIO) names Howze interim CEO; McDonough to chair board Stock Titan

Generation Bio Announces 1-for-10 Reverse Stock Split - Yahoo Finance

Generation Bio Announces 1-for-10 Reverse Stock Split Yahoo Finance

Generation jettisons 90% of employees due to lack of time, cash to develop autoimmune tech - Fierce Biotech

Generation jettisons 90% of employees due to lack of time, cash to develop autoimmune tech Fierce Biotech

Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position - Nasdaq

Generation Bio Co. Advances T Cell-Selective siRNA Therapeutics for Autoimmune Diseases, Announces Robust Financial Position Nasdaq

Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves - BioSpace

Generation Bio Boots 90% of Staff Amid Dwindling Cash Reserves BioSpace

Generation Bio's T Cell Delivery Success Leads to Strategic Review as Company Cuts 90% of Workforce - Stock Titan

Generation Bio's T Cell Delivery Success Leads to Strategic Review as Company Cuts 90% of Workforce Stock Titan

Generation Bio Grants $41K Worth of Stock Options Under New Incentive Plan - Stock Titan

Generation Bio Grants $41K Worth of Stock Options Under New Incentive Plan Stock Titan

Generation Bio Announces the Presentation of Preclinical - GlobeNewswire

Generation Bio Announces the Presentation of Preclinical GlobeNewswire

Generation Bio Plans 1-for-10 Reverse Split: What This Means for 67.3M Shares and Nasdaq Status - Stock Titan

Generation Bio Plans 1-for-10 Reverse Split: What This Means for 67.3M Shares and Nasdaq Status Stock Titan

The Global Nanomedicine Market: Key Players and Emerging Technologies in Healthcare - AZoNano

The Global Nanomedicine Market: Key Players and Emerging Technologies in Healthcare AZoNano

Generation Bio Announces Demonstration of Highly Selective - GlobeNewswire

Generation Bio Announces Demonstration of Highly Selective GlobeNewswire

Generation Bio Names Phillip Samayoa, Ph.D. as Chief Strategy Officer - citybiz

Generation Bio Names Phillip Samayoa, Ph.D. as Chief Strategy Officer citybiz

Generation Bio (GBIO) Stock Price, News & Analysis - MarketBeat

Generation Bio (GBIO) Stock Price, News & Analysis MarketBeat

GBIO Stock Price and Chart — NASDAQ:GBIO - TradingView

GBIO Stock Price and Chart — NASDAQ:GBIO TradingView

Companies like Generation Bio

Editas Medicine logo - Similar company to Generation Bio

Editas Medicine

232
Orna Therapeutics logo - Similar company to Generation Bio

Orna Therapeutics

166
Verve Therapeutics logo - Similar company to Generation Bio

Verve Therapeutics

309
Intellia Therapeutics, Inc. logo - Similar company to Generation Bio

Intellia Therapeutic...

446
Alnylam Pharmaceuticals logo - Similar company to Generation Bio

Alnylam Pharmaceuticals

2.58K
Tessera Therapeutics logo - Similar company to Generation Bio

Tessera Therapeutics

326
Generate:Biomedicines logo - Similar company to Generation Bio

Generate:Biomedicines

325
Beam Therapeutics logo - Similar company to Generation Bio

Beam Therapeutics

557
Flagship Pioneering logo - Similar company to Generation Bio

Flagship Pioneering

772
Vertex Pharmaceuticals logo - Similar company to Generation Bio

Vertex Pharmaceuticals

6.09K

Top Generation Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant